Pleural fluid from tuberculous pleurisy inhibits the functions of T cells and the differentiation of Th1 cells via immunosuppressive factors

Cellular and Molecular Immunology

Volumn 8, Issue 2, 2011, Pages 172-180

  Li, Qin ^a   Li, Li ^a   Liu, Yun ^a   Fu, Xiaoying ^a   Qiao, Dan ^a   Wang, Hui ^a   Lao, Suihua ^b   Huang, Fengyu ^c   Wu, Changyou ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU CHEST HOSPITAL   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

suppressive factors; Th1 cytokine; Th1 differentiation; tuberculosis pleurisy

Indexed keywords

ADENOSINE; INDOLEAMINE 2,3 DIOXYGENASE; INDOLEAMINE 2,3 DIOXYGENASE INHIBITOR; INTERLEUKIN 10; NEUTRALIZING ANTIBODY; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CYCLE PROGRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IMMUNE STATUS; IMMUNOPATHOGENESIS; INHIBITION KINETICS; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MALE; PATHOPHYSIOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; PLEURA FLUID; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TUBERCULOUS PLEURISY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BODY FLUIDS; CD8-POSITIVE T-LYMPHOCYTES; CELL CYCLE; CELL DIFFERENTIATION; CYTOKINES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; SIGNAL TRANSDUCTION; TH1 CELLS; TUBERCULOSIS, PLEURAL; YOUNG ADULT;

EID: 79952369015     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2010.80     Document Type: Article

References (37)

1. Ferrer J. Pleural tuberculosis. Eur Respir J 1997; 10: 942-947. (Pubitemid 27180212)
2. Porcel JM. Tuberculous pleural effusion. Lung 2009; 187: 263-270.
3. Light RW, Macgregor MI, Luchsinger PC, Ball WJ. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med 1972; 77: 507-513.
4. Aleman M, de la Barrera SS, Schierloh PL, Alves L, Yokobori N, Baldini M et al. In tuberculous pleural effusions, activated neutrophils undergo apoptosis and acquire a dendritic cell-like phenotype. J Infect Dis 2005; 192: 399-409. (Pubitemid 41023118)
5. Saka H, Shimokata K. Stateof theart: treatmentof malignant pleural and pericardial effusions. Gan To Kagaku Ryoho 1997; 24(Suppl 3): 418-425. Japanese.
6. Schwander SK, Torres M, Carranza CC, Escobedo D, Tary-Lehmann M, Anderson P et al. Pulmonary mononuclear cell responses to antigens of Mycobacterium tuberculosis in healthy household contacts of patients with active tuberculosis and healthy controlsfrom the community. J Immunol 2000; 165: 1479-1485. (Pubitemid 30604581)
7. Bonecini-Almeida MG, Ho JL, Boechat N, Huard RC, Chitale S, Doo H et al. Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TGF-beta receptors I and II in active tuberculosis. Infect Immun 2004; 72: 2628-2634. (Pubitemid 38542389)
8. Mellor A. Indoleamine 2, 3 dioxygenase and regulation of T cell immunity. Biochem Biophys Res Commun 2005; 338: 20-24. (Pubitemid 41540532)
9. + Tcell alloantigen-specific hyporesponsiveness by IL-10 and TGF-beta. J Immunol 1999; 163: 3684-3691. (Pubitemid 29450890)
10. Stone TW, Darlington LG. Endogenous kynurenines as targets for drug discovery and development. Nat Rev Drug Discov 2002; 1: 609-620. (Pubitemid 37361524)
11. 2A adenosinereceptor as a physiological immunosuppressor and to engineer inflammation in vivo. Biochem Pharmacol 2003; 65: 493-501. (Pubitemid 36144234)
12. Driver AG, Kukoly CA, Ali S, Mustafa SJ. Adenosine in bronchoalveolar lavagefluid in asthma. Am Rev Respir Dis 1993; 148: 91-97.
13. Huszar E, Vass G, Vizi E, Csoma Z, Barat E, Molnar VG et al. Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma. Eur Respir J 2002;20:1393-1398. (Pubitemid 35469046)
14. Huszar E, Horvath I, Barat E, Herjavecz I, Boszormenyi-Nagy G, Kollai M. Elevated circulating adenosine level potentiates antigen-induced immediate bronchospasm and bronchoconstrictor mediator release in sensitized guinea pigs. J Allergy Clin Immunol 1998; 102: 687-691.
15. Jalapathy KV, Prabha C, Das SD. Correlates of protective immune response in tuberculous pleuritis. FEMS Immunol Med Microbiol 2004; 40: 139-145. (Pubitemid 38249538)
16. Barnes PF, Lu S, Abrams JS, Wang E, Yamamura M, Modlin RL.Cytokineproductionat the site of disease in human tuberculosis. Infect Immun 1993; 61: 3482-3489. (Pubitemid 23223442)
17. Condos R, Rom WN, Liu YM, Schluger NW. Local immune responses correlate with presentation and outcome in tuberculosis. Am J Respir Crit Care Med 1998; 157: 729-735.
18. Hernandez-Pando R, Orozco H, Aguilar D. Factors that deregulate the protective immune response in tuberculosis. Arch Immunol Ther Exp (Warsz) 2009; 57: 355-367.
19. Ho JL, Lapa ES. Promotion of a down-modulated lung immune state may be a strategy by M. tuberculosis to foster active disease and persistence. Discov Med 2010; 9: 34-41.
20. Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations. Annu Rev Immunol 2010; 28: 445-489.
21. Collins HL, Kaufmann SH. The many faces of host responses to tuberculosis. Immunology 2001; 103: 1-9. (Pubitemid 32453093)
22. Sahiratmadja E, Alisjahbana B, de Boer T, Adnan I, Maya A, Danusantoso H et al. Dynamic changes in pro-and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment. Infect Immun 2007; 75: 820-829. (Pubitemid 46203445)
23. Taha RA, Kotsimbos TC, Song YL, Menzies D, Hamid Q. IFN-gamma and IL-12 are increased in active compared with inactive tuberculosis. Am J Respir Crit Care Med 1997;155:1135-1139. (Pubitemid 27133436)
24. Taylor MW, Feng GS. Relationship between interferon-gamma, indoleamine 2, 3-dioxygenase, and tryptophan catabolism. FASEB J 1991; 5: 2516-2522. (Pubitemid 21905800)
25. Hwu P, Du MX, Lapointe R, Do M, Taylor MW, Young HA. Indoleamine 2, 3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J Immunol 2000; 164: 3596-3599. (Pubitemid 30169812)
26. Mellor AL, Munn DH. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 2004; 4: 762-774. (Pubitemid 39336293)
27. 2A receptors. Annu Rev Immunol 2004; 22:657-682. (Pubitemid 38680437)
28. 2A receptor signaling promotes peripheral toleranceby inducingT-cell anergyandthegeneration of adaptive regulatory T cells. Blood 2008; 111: 251-259.
29. Cushley MJ, Tattersfield AE, Holgate ST. Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. 1983. Br J Clin Pharmacol 2004; 58: S751-S758.
30. Montesinos MC, Yap JS, Desai A, Posadas I, McCrary CT, Cronstein BN. Reversalof the antiinflammatory effects of methotrexate by the nonselective adenosine receptor antagonists theophylline and caffeine: evidencethat the antiinflammatory effects of methotrexate are mediated via multiple adenosine receptors in rat adjuvant arthritis. Arthritis Rheum 2000; 43: 656-663. (Pubitemid 30394958)
31. Law WR. Adenosine receptors in the response to sepsis: what do receptor-specific knockoutstell us? Am J Physiol Regul Integr Comp Physiol 2006; 291: R957-R958. (Pubitemid 44498435)
32. 2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatorybowel disease. Gastroenterology 2005; 129: 26-33. (Pubitemid 41002039)
33. 2A receptor agonists promote more rapid wound healing than recombinant human platelet-derived growth factor (Becaplermin gel). Inflammation 2002; 26: 19-24. (Pubitemid 34226179)
34. 2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood 1997; 90: 1600-1610. (Pubitemid 27355433)
35. + T cells. J Immunol 2005; 174: 1073-1080. (Pubitemid 40094304)
36. deWaal MR, Haanen J, Spits H, Roncarolo MG, Te VA, Figdor C et al. Interleukin 10 (IL-10) andviral IL-10strongly reduceantigen-specific humanT cell proliferation by diminishingtheantigen-presentingcapacityof monocytes viadownregulationof class II major histocompatibilitycomplexexpression. J Exp Med 1991; 174: 915-924.
37. Almeida AS, Lago PM, Boechat N, Huard RC, Lazzarini LC, Santos AR et al. Tuberculosis is associated with a down-modulatory lung immune response that impairs Th1-type immunity. J Immunol 2009; 183: 718-731.